GlassScriptPhysician profile
Emily J Jones
NPI 1053177006
$2,415.67
in general payments reported to CMS, 2019-2025
20 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $834 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,256 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,255.73 |
| Education | $159.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $468.71 | 2024-2025 | |
| Abbvie INC. | $262.32 | 2024-2025 | |
| Harmony Biosciences LLC | $219.03 | 2025 | |
| Ucb, INC. | $196.86 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $196.83 | 2024-2025 | Dupixent |
| Revance Therapeutics, INC. | $196.26 | 2024-2025 | Daxi, Daxxify |
| Novartis Pharmaceuticals Corporation | $126.04 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $107.12 | 2024-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $105.88 | 2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $94.99 | 2024 | |
| Arcutis Biotherapeutics, INC. | $88.10 | 2025 | Zoryve |
| Incyte Corporation | $75.23 | 2024-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $66.49 | 2024-2025 | |
| Lnhc, INC | $57.89 | 2025 | Zelsuvmi |
| Botanix Sb INC | $33.15 | 2025 | Sofdra |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $26.56 | 2024 | Ycanth |
| Hill Dermaceuticals, INC. | $26.50 | 2025 | Tolak |
| Amgen INC. | $26.30 | 2025 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.08 | 2024 | Arazlo, Cabtreo, Jublia |
| Leo Pharma INC. | $19.33 | 2025 | Anzupgo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.